The Cancer Immunology and Immunotherapy Center (CIIC) was founded in 1996 to investigate the field of cancer immunology, which is based on the premise that the body's immune system can be mobilized against cancer. This field, which CIIC helped progress, has provided the basis for the development of cancer immunotherapy.

The center has established close links with clinical oncology departments and collaboration with leading universities and research centers in Europe and the USA. Within CIIC, highly qualified scientists with clinical and/or laboratory experience in different fields of oncology, are working together to establish a network for practical and effective research, the overall objective being to rapidly translate basic scientific results into clinical applications.

Research at the Cancer Immunology and Immunotherapy Center (CIIC) is dedicated to experimental cancer research, in close collaboration with the adjacent "Saint Savas" Cancer Hospital.

The research conducted at the CIIC is focused in the scientific fields of:

1. Cellular Immunology
2. Molecular Immunology
3. Cellular Cancer Immunotherapy
4. Cancer drug targets
5. Cancer Vaccines
6. NK cell development and Immunotherapy
7. Production of monoclonal antibodies to tumor-associated antigens